Trial ChiCTR2000029868
Publication Tang W, Bmj, 2020
Primary outcome on the report: The primary outcome for this trial was whether patients had a negative conversion of SARS–CoV–2 by 28 days and whether patients with severe COVID–19 had a clinical improvement by 28 days.